Načítá se...

Emerging role of multikinase inhibitors for refractory thyroid cancer

Thyroid cancer incidence continues to increase, remaining the most common endocrine malignancy. The need for effective systemic therapies combined with high incidence of driver mutations and overexpression of molecular pathways make refractory thyroid cancer an ideal candidate for treatment with nov...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Perez, Cesar A, Arango, Belisario A, Velez, Michel, Raez, Luis E, Santos, Edgardo S
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2012
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3421474/
https://ncbi.nlm.nih.gov/pubmed/22904617
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BTT.S24465
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!